VAERS Reports UJ483AA

VAERS 1804526

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ483AA

mild

Staat: PA
Alter: 91,0
Geschlecht: F
Eingang: 21.10.2021
Impfdatum: 23.10.2020
Beginn: 24.10.2020
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Arthropathy Aspiration joint Exostosis Immediate post-injection reaction Pain Swelling Ultrasound Doppler abnormal White blood cell count decreased X-ray limb abnormal

Symptomtext

Patient with complaints of shoulder pain almost immediately after immunization. Swelling, pain,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: 10/24- ZPAK, 10/26 -Xray right shoulder (inferior acromial spur, moderate glenohumeral joint arthropathy), US, Synovial fluid collection 10/28, 10/28 appt with orthopedics (leukocytes 1,774 (abnormal)
Aktuelle Erkrankungen: Cervicalgia, , lumbar radiculopathy, migraine, SNHL, Atherosclerosis, HTN, Left atrial enlargement, PVD, Mitral regurgitation, TIA, CAD, GERD, Osteoarthritis, Hyperlipidemia, Anemia, Anxiety, Ischemic colitis
Vorgeschichte: see above #11
Andere Medikamente: Tramadol, Proair, Amlodipine-Benazepril, Famotidine, Hydralazine, Ferrous sulfate, Atorvastatin, Carvedilol,
Allergien: Exforge, Cipro, Oxycodone-ace, codeine, lactose
Vorherige Impfungen: -

VAERS 1653335

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ483AA

mild

Staat: NJ
Alter: 81,0
Geschlecht: F
Eingang: 29.08.2021
Impfdatum: 29.09.2020
Beginn: 29.09.2020
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abnormal behaviour Delirium Hallucination Memory impairment Vomiting

Symptomtext

delirium; does not remember anything from that time; she was talking to her father who had died 10 years before; vomited while she was on her couch; Initial information received on 05-Aug-2021 regarding an unsolicited valid serious case received from a consumer/non-Healthcare professional via Medical Information (Reference number 00711987). This case involves 81-year-old female patient who experienced delirium, vomited while she was on her couch (vomiting), does not remember anything from that time (memory impairment) and she was talking to her father who had died 10 years before (abnormal behaviour) after receiving INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. The patient's past vaccination(s) included FLUZONE HIGH-DOSE QUADRIVALENT and experienced no issues. The patient's medical history included urticaria. The patient's past medical treatment(s) and family history were not provided. Concomitant medications included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Urticaria. On 29-Sep-2020, the patient received dose of 0.7ml suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ483AA and expiry date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. On 29-Sep-2020, the patient developed a serious delirium (lasted two days) on the same day following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. This event was assessed as medically significant. On 29-Sep-2020, the patient developed a non-serious vomited while she was on her couch (vomiting), does not remember anything from that time (memory impairment) and she was talking to her father who had died 10 years before (abnormal behaviour) on the same day following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. It was reported that, patient had a reaction to last year's (2020-2021) Fluzone High-Dose Quadrivalent vaccine, and wanted to know the ingredients so that patient and her doctor could compare them to the ingredients in the Covid-19 vaccine. Relevant laboratory tests were not reported. It was not reported if the patient received any corrective treatment for all the events. At time of reporting, the outcome was resolved on an unknown date for the events.; Sender's Comments: This case involves an 81-year-old female patient who had delirium, vomiting, memory impairment and abnormal behavior after receiving FLUZONE HIGH-DOSE QUADRIVALENT. The time to onset is compatible. There is no further information regarding patient's medical condition at time of vaccination, history and laboratory tests ruling out alternate etiologies. Based upon the reported information, the role of a vaccine cannot be assessed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vomiting
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Urticaria (which she takes Allegra and Pepcid to treat and prevent)
Andere Medikamente: ALLEGRA; PEPCID [FAMOTIDINE]
Allergien: -
Vorherige Impfungen: -